5.10
Dariohealth Corp stock is traded at $5.10, with a volume of 8,380.
It is down -6.42% in the last 24 hours and down -24.44% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
See More
Previous Close:
$5.45
Open:
$5.45
24h Volume:
8,380
Relative Volume:
0.43
Market Cap:
$49.98M
Revenue:
$22.36M
Net Income/Loss:
$-33.61M
P/E Ratio:
-0.53
EPS:
-9.6235
Net Cash Flow:
$-26.08M
1W Performance:
-6.08%
1M Performance:
-24.44%
6M Performance:
-32.09%
1Y Performance:
-62.22%
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DRIO
Dariohealth Corp
|
5.10 | 49.98M | 22.36M | -33.61M | -26.08M | -9.6235 |
|
VEEV
Veeva Systems Inc
|
311.15 | 50.38B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
70.14 | 12.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
62.17 | 12.30B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
105.42 | 8.51B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.47 | 7.65B | 1.34B | 230.70M | 440.96M | 2.6695 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-26 | Initiated | Alliance Global Partners | Buy |
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
Form 4 DarioHealth Corp For: 29 September By Investing.com - Investing.com UK
DarioHealth (DRIO) director John R. Palumbo receives shares that vest after two years - Stock Titan
After a restricted share award, DarioHealth (DRIO) director Dennis McGrath holds 88,737 shares directly. - Stock Titan
DarioHealth (DRIO) director Adam Stern's share award brings his direct holdings to 57,717 shares - Stock Titan
Eight quarterly installments over two years: DarioHealth (DRIO) director Yoav Shaked receives 54,000 shares. - Stock Titan
A 95,000-share award for DarioHealth (DRIO)'s finance chief vests over two years. - Stock Titan
A 95,000-share grant to DarioHealth (DRIO) COO Lara Ann Sherman won't vest immediately. - Stock Titan
DarioHealth (DRIO) CEO's 297,000-share award is scheduled to vest in eight quarterly installments. - Stock Titan
DarioHealth (DRIO) director Karah Hila holds 58,965 shares after a restricted share award. - Stock Titan
DarioHealth (DRIO) director Dennis Matheis acquires 44,000 restricted shares that vest after two years. - Stock Titan
A New Jersey health plan covering about 1.5 million people is set to offer Dario care - Stock Titan
DarioHealth Corp. (DRIO) Stock Price & News - Syfe
DarioHealth stock holds near USD 71 million market value - ad-hoc-news.de
DarioHealth announces board member retirement, governance remains stable - TipRanks
Lawrence Leisure to Retire from DarioHealth Board - TradingView
DarioHealth Corp. (DRIO) Gains 2.07% as Shares Test Key Resistance ZoneHidden Order - dars.gov.et
DarioHealth Corp (NASDAQ: DRIO) Share Price, DRIO Stock News, DRIO Share Price & Updates - kalkine.ca
DarioHealth expects DarioIQ to boost recurring revenue by 10-15% - scanx.trade
DarioHealth (DRIO) Upgraded to Buy: Here's Why - Eastern Progress
DARIOHEALTH CORP : ALLIANCE GLOBAL PARTNERS INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $12 - Bitget
DarioHealth (NASDAQ:DRIO) Now Covered by Analysts at Alliance Global Partners - MarketBeat
DarioHealth Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Some Analysts Just Cut Their DarioHealth Corp. (NASDAQ:DRIO) Estimates - simplywall.st
Analysts Have Made A Financial Statement On DarioHealth Corp.'s (NASDAQ:DRIO) Second-Quarter Report - simplywall.st
AI Chronic Care Platform Adds Fifth Fortune 50 Client, Lifts Margin to 62% - Streetwise Reports
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $8.00 at TD Cowen - MarketBeat
DarioHealth Reports Q2 Revenue, with 62% Gross Margin as AI Platform Expands - Streetwise Reports
DarioHealth earnings beat by $0.40, revenue fell short of estimates - Investing.com Nigeria
DarioHealth (DRIO) Q2 2026 Earnings Call Transcript - AOL.com
DarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ... - finance.yahoo.com
DarioHealth revenue slips 4% to $5.2 million - grafa.com
DarioHealth Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
DarioHealth Releases Q2 2026 Financial Results - AlphaStreet
DarioHealth (NASDAQ:DRIO) Issues Quarterly Earnings Results, Beats Estimates By $0.37 EPS - MarketBeat
DarioHealth Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: DarioHealth tops q2 2026 EPS forecast, misses revenue - Investing.com Australia
DarioHealth Corp reports results for the quarter ended June 30Earnings Summary - TradingView
DarioHealth Q2 Results: Adj. EPS beats estimates, sales miss - scanx.trade
Earnings call transcript: DarioHealth tops q2 2026 EPS forecast, misses revenue - Investing.com
DarioHealth Corp (DRIO) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
DarioHealth earnings beat by $0.40, revenue fell short of estimates - Investing.com
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
DarioHealth earnings beat by $0.40, revenue fell short of estimates - Investing.com UK
DarioHealth Reports Second Quarter 2026 Financial Results - PR Newswire
DarioHealth Corp. 2Q 2026: Revenue $5.18M, Net loss $7.92M — 10-Q Summary - TradingView
DarioHealth (DRIO) Holds Ground Near $7.67 as Buyers Defend Key SupportMonthly Profile - vinanet.vn
DarioHealth Corp. (DRIO) stock price, news, quote and history - Yahoo Finance Australia
DARIOHEALTH Q2 2026 Earnings Preview: Recent $DRIO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
DarioHealth Corp expected to post a loss of $1.21 a shareEarnings Preview - TradingView
Digital Health Provider Launches Women's Health & Sleep Solutions - Streetwise Reports
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):